Health and vision related quality of life among patients with choroidal neovascular age related macular degeneration

Picoto, Maria; Galveia, José; Patrício, Sara; Rodrigues, António; Vaz, F

doi:10.5935/0034-7280.20150044

Cited by 3 publications

(3 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In France, AMD is the leading cause of blindness in population over 50 years, with a prevalence of 8.50% and increasing with age reaching up to 27.9% in people over 75 years (3,4) . It decreases the reading and driving abilities, as well as all activities that need an accurate sight (5,6) . It is expected a 50% increase in number of individuals affected by AMD until 2020 (7) .…”

Section: Introductionmentioning

confidence: 99%

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil

Pradella¹,

Nisihara²,

Sato³

et al. 2016

Revista Brasileira De Oftalmologia

View full text Add to dashboard Cite

Objective: To evaluate the profile and severity of age-related macular degeneration (AMD) in ophthalmology ambulatory of Federal University of Parana in Curitiba, Parana, Brazil. Methods: This was a cross-sectional study with data collected among the 6155 outpatients ophthalmic appointments (november 2011 to november 2013) Comparando com a literatura, uma maior proporção de casos avançados de DMRI (50% de forma exsudativa) foi encontrada. Em relação à etnia, tabagismo e IMC, não houve diferença entre pacientes com forma exsudativa e não exsudativa. Estes resultados podem ser comparados com estudos disponíveis, considerando a pouca informação referente a DMRI existente no Brasil.

show abstract

Section: Introductionmentioning

confidence: 99%

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil

Pradella¹,

Nisihara²,

Sato³

et al. 2016

Revista Brasileira De Oftalmologia

View full text Add to dashboard Cite

show abstract

“…Evidence further showed that loss of vision affected the overall well-being of an individual, increased dependency levels, and caused social isolation. The evaluation of vision-related QoL among patients with nAMD may act as a tool for clinicians to aid in the therapeutic decision-making process [17].…”

Section: Burden and Consequences Of Namdmentioning

confidence: 99%

“…The physical and psychological burden of nAMD is compounded, as the disease mainly impacts older patients whose vision might be already deteriorating due to coexisting ocular and other systemic diseases [15]. Altogether, these act as significant stressors for patients, further increasing the disease burden [17,24]. Although there is ample global evidence highlighting the physical and psychological burden of nAMD, there is limited evidence from the Indian subcontinent.…”

Section: Burden and Consequences Of Namdmentioning

confidence: 99%

Treatment Burden and Quality of Life of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Their Caregivers—A Review

Biswas¹,

Roy²,

Maksane³

et al. 2021

IJOVS

View full text Add to dashboard Cite

The growing incidence of neovascular age-related macular degeneration (nAMD) in India and its debilitating consequences, such as physical, psychological, and emotional stress, are a cause of significant concern. Failing eyesight due to nAMD hinders the ability of patients to perform daily tasks, leading to dependency on others -often resulting in anxiety and depression. Although treatment options such as anti-vascular endothelial growth factors (anti-VEGFs) are readily available, long-term treatment compliance is often compromised. Thus, it is important for health care providers to be aware of the burden associated with nAMD for both patients and caregivers. India, with its large urban and rural population base, faces varied challenges in health care accessibility and affordability. Further, there is a paucity of India-specific studies to ascertain patient and caregiver burden related to nAMD. A deeper understanding of disease awareness and treatment expectations from an Indian perspective may further help clinicians to provide optimum management to patients. The current review provides insights into the quality of life (QoL) and treatment-related burden for patients with nAMD and their caregivers. Further, it emphasizes the need of PAN-India studies to ascertain the patient and caregiver burden related to nAMD, which may assist in devising treatment algorithms and pricing policies suited to the Indian population and enable patients to receive quality eye care.

show abstract

Vision-Related Quality of Life, Anxiety and Depression in Congolese Patients with Polypoidal Choroidal Vasculopathy

Kabedi

Kayembe

Mwanza

2020

Seminars in Ophthalmology

View full text Add to dashboard Cite

Health and vision related quality of life among patients with choroidal neovascular age related macular degeneration

Cited by 3 publications

References 15 publications

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil

Treatment Burden and Quality of Life of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Their Caregivers—A Review

Vision-Related Quality of Life, Anxiety and Depression in Congolese Patients with Polypoidal Choroidal Vasculopathy

Contact Info

Product

Resources

About